Véronique Capuano

Véronique Capuano

Auto-generated profile, based on publicly available information

Véronique Capuano

Département de Biochimie et Génétique Moléculaire, Institut Pasteur, Paris, France

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 1997 in Nature
Verified
Journal Article
Open access
PDF file
FKF. Kunst
F. Kunst
NON. Ogasawara
N. Ogasawara
IMI. Moszer
I. Moszer
AAA. M. Albertini
A. M. Albertini
GAG. Alloni
G. Alloni
ADAntoine Danchin
Antoine Danchin
Bacillus subtilis is the best-characterized member of the Gram-positive bacteria. Its genome of 4,214,810 base pairs comprises 4,100 protein-coding genes. Of these protein-coding genes, 53% are represented once, while a quarter of the genome corresponds to several gene families that have been greatly expanded by gene duplication, the largest family containing 77 putative ATP-binding transport proteins. In addition, a large proportion of the genetic capacity is devoted to the utilization of a variety of carbon sources, including many plant-derived molecules. The identification of five signal peptidase genes, as well as several genes for components of the secretion apparatus, is important given the capacity of Bacillus strains to secrete large amounts of industrially important enzymes. Many of the genes are involved in the synthesis of secondary metabolites, including antibiotics, that are more typically associated with Streptomyces species. The genome contains at least ten prophages or remnants of prophages, indicating that bacteriophage infection has played an important evolutionary role in horizontal gene transfer, in particular in the propagation of bacterial pathogenesis.

Verified
Journal Article
Open access
PDF file
MLMélanie Lambert
Mélanie Lambert
VCVéronique Capuano
Véronique Capuano
AOAndrea Olschewski
Andrea Olschewski
JSJessica Sabourin
Jessica Sabourin
Nagaraj ChandranNagaraj Chandran
Nagaraj Chandran
Fabrice AntignyFabrice Antigny
Fabrice Antigny
Pulmonary arterial hypertension (PAH) is a multifactorial and severe disease without curative therapies. PAH pathobiology involves altered pulmonary arterial tone, endothelial dysfunction, distal pulmonary vessel remodeling, and inflammation, which could all depend on ion channel activities (K+, Ca2+, Na+ and Cl−). This review focuses on ion channels in the pulmonary vasculature and discusses their pathophysiological contribution to PAH as well as their therapeutic potential in PAH.

1 October 1988 in Photosynthesis Research
Verified
Journal Article
Closed access
PDF file
NMNicole Tandeau De Marsac
Nicole Tandeau De Marsac
DMDidier Mazel
Didier Mazel
TDThierry Damerval
Thierry Damerval
GGGérard Guglielmi
Gérard Guglielmi
VCVeronique Capuano
Veronique Capuano
JHJean Houmard
Jean Houmard

12 December 2003 in Circulation Research
Verified
Journal Article
Closed access
PDF file
LFLaurent Ferron
Laurent Ferron
VCVérOnique Capuano
VérOnique Capuano
YRYann Ruchon
Yann Ruchon
EDEdith Deroubaix
Edith Deroubaix
ACAlain Coulombe
Alain Coulombe
JRJean-FrançoIs Renaud
Jean-FrançoIs Renaud
Recent studies indicate that cardiac T-type Ca 2+ current ( I CaT ) reappears in hypertrophied ventricular cells. The aim of this study was to investigate the role of angiotensin II (Ang II), a major inducer of cardiac hypertrophy, in the reexpression of T-type channel in left ventricular hypertrophied myocytes. We induced cardiac hypertrophy in rats by abdominal aorta stenosis for 12 weeks and thereafter animals were treated for 2 weeks with losartan (12 mg/kg per day), an antagonist of type 1 Ang II receptors (AT 1 ). In hypertrophied myocytes, we showed that the reexpressed I CaT is generated by the Ca V 3.1 and Ca V 3.2 subunits. After losartan treatment, I CaT density decreased from 0.40±0.05 pA/pF (n=26) to 0.20±0.03 pA/pF (n=27, P <0.01), affecting Ca V 3.1- and Ca V 3.2-related currents. The amount of Ca V 3.1 mRNA increased during hypertrophy and retrieved its nonhypertrophic level after losartan treatment, whereas the amount of Ca V 3.2 mRNA was unaffected by stenosis. In cultured newborn ventricular cells, chronic Ang II application (0.1 μmol/L) also increased I CaT density and Ca V 3.1 mRNA amount. UO126, a mitogen-activated protein kinase kinase-1/2 (MEK1/2) inhibitor, reduced Ang II–increased I CaT density and Ca V 3.1 mRNA amount. Bosentan, an endothelin (ET) receptor antagonist, reduced Ang II–increased I CaT density without affecting the amount of Ca V 3.1 mRNA. Finally, cotreatment with bosentan and UO126 abolished the Ang II–increased I CaT density. Our results show that AT 1 -activated MEK pathway and autocrine ET-activated independent MEK pathway upregulate T-type channel expression. Ang II–increased of I CaT density observed in hypertrophied myocytes may play a role in the pathogenesis of Ca 2+ overload and arrhythmias seen in cardiac pathology.

19 January 2018 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
MLMélanie Lambert
Mélanie Lambert
ABAngèle Boet
Angèle Boet
CRCatherine Rucker-Martin
Catherine Rucker-Martin
PFPedro Ferreira
Pedro Ferreira
VCVéronique Capuano
Véronique Capuano
Fabrice AntignyFabrice Antigny
Fabrice Antigny
Mutations in the KCNK3 gene, which encodes for an outward-rectifier K+ channel, have been identified in patients suffering from pulmonary arterial hypertension (PAH), and constitute the first described channelopathy in PAH. In human PAH and experimental pulmonary hypertension (PH), we demonstrated that KCNK3 expression and function are severely reduced in pulmonary vascular cells, promoting PH-like phenotype at the morphologic and haemodynamic levels. Since KCNK3 channel is also expressed in both the human and rodent heart, we aimed to elucidate the pathophysiological role of KCNK3 channel in right ventricular (RV) hypertrophy (RVH) related to PH. Using whole-cell Patch-clamp technique, we demonstrated that KCNK3 is predominantly expressed in adult rat RV cardiomyocytes compared to the left ventricle cardiomyocytes and participates in the repolarizing phase of the RV action potential. We revealed a reduction in KCNK3 function prior to development of RVH and the rise of pulmonary vascular resistance. KCNK3 function is severely reduced in RV cardiomyocytes during the development of RVH in several rat models of PH (exposure to monocrotaline, chronic hypoxia, and Sugen/hypoxia) and chronic RV pressure overload (pulmonary artery banding). In experimental PH, we revealed a reduction in KCNK3 function before any rise in pulmonary vascular resistance and the development of RVH. KCNK3 mRNA level is also reduced in human RV tissues from PAH patients compared to non-PAH patients. In line with these findings, chronic inhibition of KCNK3 in rats with the specific inhibitor (A293) induces RV hypertrophy which is associated with the re-expression of foetal genes, RV fibrosis, RV inflammation, and subsequent loss of RV performance as assessed by echocardiography. Our data indicate that loss of KCNK3 function and expression is a hallmark of the RV hypertrophy/dysfunction associated with PH.

1 March 1990 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JHJ Houmard
J Houmard
VCV Capuano
V Capuano
MCM V Colombano
M V Colombano
TCT Coursin
T Coursin
NMN Tandeau de Marsac
N Tandeau de Marsac
Cyanobacteria harvest light energy through multimolecular structures, the phycobilisomes, regularly arrayed at the surface of the photosynthetic membranes. Phycobilisomes consist of a central core from which rods radiate. A large polypeptide (LCM, 75-120 kDa) is postulated to act both as terminal energy acceptor and as a linker polypeptide that stabilizes the phycobilisome architecture. We report here the characterization of the gene (apcE) that encodes this LCM polypeptide in Calothrix sp. PCC 7601. It is located upstream from the genes encoding the major components of the phycobilisome core (allophycocyanin) and is part of the same operon. The deduced amino acid sequence shows that the N-terminal region of LCM shares homology with the other phycobiliprotein subunits and thus constitutes the chromoprotein domain. The other part of the molecule is made up of four repeated domains that are highly homologous to the N-terminal regions of the phycocyanin rod linker polypeptides. The predicted secondary structure of the different domains of the LCM is discussed in relation to the different roles and properties of this large molecule.